India's Emerging Advanced Therapy Landscape Cell and Gene therapies — and chimeric antigen receptor T-cell (CAR-T) therapies in particular — represent one of the most transformative frontiers in modern medicine. With a...

For global Pharmaceutical companies evaluating emerging market expansion, three regions consistently dominate strategic discussions: India, ASEAN, and the GCC. Each offers compelling growth characteristics. Each carries a distinct regulatory architecture, commercial structure,...

Why India Demands a Dedicated Biosimilar Strategy India is one of the fastest-growing Biosimilar markets in the world, driven by a large patient population, expanding government healthcare coverage under Ayushman Bharat, and...

Pharmaceutical acquisitions are complex, high-stakes transactions. Financial modelling, commercial valuation, and market positioning typically receive the most intensive scrutiny. Yet the most consequential risks in many transactions are neither financial nor commercial...